Cryo-Cell International, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Patent Option Agreement - Additional Information (Detail)

Patent Option Agreement - Additional Information (Detail) - USD ($)					12 Months Ended
	Feb. 04, 2022	Feb. 23, 2021	Dec. 01, 2020	Jun. 30, 2020	Nov. 30, 2021	Nov. 30, 2020	Mar. 08, 2021	Feb. 28, 2021
Patent Option Agreement [Line Items]
Long-term line of credit				$ 350,000
Line of credit facility			$ 150,000	$ 150,000
Revenue					$ 28,884,902	$ 31,147,593
Duke University [Member]
Patent Option Agreement [Line Items]
License fee payable			$ 12,000,000
License fee transferred							$ 4,889,410
Milestone payments first phase III clinical trial		$ 2,000,000
Capitalized costs to obtain agreement								$ 15,372,382
Present value of license fee					12,000,000
Number of common stock value transferred					$ 3,585,172
Number of common stock shares transferred					409,734
Capitalized costs amortization period					16 years
Amortization expense					$ 720,580
Duke University [Member] \| Subsequent Event [Member]
Patent Option Agreement [Line Items]
Milestone payments first phase III clinical trial	$ 2,000,000
Duke University [Member] \| 5.0% upon Execution of the Agreement [Member] \| Fully Diluted Equity Ownership
Patent Option Agreement [Line Items]
Common Stock Equal Full Diluted Equity Ownership Outstanding Percentage		5.00%
Duke University [Member] \| 2.5% Market Cap [Member] \| Fully Diluted Equity Ownership
Patent Option Agreement [Line Items]
Common Stock Equal Full Diluted Equity Ownership Outstanding Percentage		2.50%
Duke University [Member] \| Minimum [Member]
Patent Option Agreement [Line Items]
Royalties Percentage Portion of Net Sales		7.00%
Duke University [Member] \| Minimum [Member] \| 2.5% Market Cap Triggers with 18 Months [Member] \| Fully Diluted Equity Ownership
Patent Option Agreement [Line Items]
Average Closing Market Capital		$ 300,000,000
Duke University [Member] \| Minimum [Member] \| 2.5% Market Cap Triggers with 24 Months [Member] \| Fully Diluted Equity Ownership
Patent Option Agreement [Line Items]
Average Closing Market Capital		$ 500,000,000
Duke University [Member] \| Maximum [Member]
Patent Option Agreement [Line Items]
Royalties Percentage Portion of Net Sales		12.50%
Duke University [Member] \| Within Fourteen (14) days of February 23, 2021
Patent Option Agreement [Line Items]
License fee payable		$ 5,000,000
Duke University [Member] \| First Anniversary [Member]
Patent Option Agreement [Line Items]
License fee payable		5,000,000
Duke University [Member] \| Second Anniversary [Member]
Patent Option Agreement [Line Items]
License fee payable		2,000,000
Minimum Annual Royalties Due Year Two		500,000
Minimum Annual Royalties Due Year Three		1,000,000
Minimum Annual Royalties Due Year Four		2,500,000
Minimum Annual Royalties Due Year Five		5,000,000
Minimum Annual Royalties Due After Year Five		$ 5,000,000
Duke University [Member] \| Third Anniversary [Member] \| Subsequent Event [Member]
Patent Option Agreement [Line Items]
Minimum Annual Royalties Due Year Three	500,000
Minimum Annual Royalties Due Year Four	1,000,000
Minimum Annual Royalties Due Year Five	2,500,000
Minimum Annual Royalties Due Year Six	5,000,000
Minimum Annual Royalties Due After Year Six	$ 5,000,000
Duke University [Member] \| Licensed Product and Licensed Process [Member]
Patent Option Agreement [Line Items]
Royalties Term		15 years
Duke University [Member] \| Licensed Product and Licensed Process [Member] \| 2.5% Upon Cumulative Net Sales [Member] \| Fully Diluted Equity Ownership
Patent Option Agreement [Line Items]
Common Stock Equal Full Diluted Equity Ownership Outstanding Percentage		2.50%
Revenue		$ 10,000,000
Duke University [Member] \| Licensed Product and Licensed Process [Member] \| 2.5% Upon Cumulative Net Sales [Member] \| Fully Diluted Equity Ownership
Patent Option Agreement [Line Items]
Common Stock Equal Full Diluted Equity Ownership Outstanding Percentage		2.50%
Revenue		$ 75,000,000